Nanochip could spot lymphoma relapse early
NCT ID NCT03656835
First seen Jun 27, 2026 · Last updated Aug 07, 2026 · Updated 2 times
Summary
This pilot study is testing a nanochip (ILN biochip) to see if it can monitor how well treatment is working and detect relapse in people with diffuse large B-cell lymphoma. About 73 patients will provide blood samples for the chip to analyze genetic markers. The goal is to find out if this technology can predict treatment outcomes and catch a return of the cancer sooner than standard methods.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- nanochip technology (ILN biochip)
- What this could lead to
- If successful, this nanochip could help doctors track how well lymphoma treatment is working and catch a relapse earlier than current methods.
- What could go wrong
- This is a small pilot study with only 73 participants, so results may not apply to everyone. The technology is still experimental and needs much more testing before it could be used in clinics.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIFFUSE LARGE B-CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ohio State University Comprehensive Cancer Center
Columbus, Ohio, 43210, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can immune cells plus a checkpoint drug outsmart lymphoma?
- Can an immune booster outsmart brain lymphoma?
- A shot at safer CAR t: early brain protection for lymphoma patients?
- Can donor immune cells be engineered to fight blood cancer?
- Can a simple blood test spot lymphoma earlier?
- What happens years after CAR-T therapy? a study aims to find out